Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Staining and Labeling | 18 | 2022 | 1083 | 7.320 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 38 | 2023 | 1402 | 4.510 |
Why?
|
Hodgkin Disease | 21 | 2020 | 1377 | 2.720 |
Why?
|
Lymphoma, B-Cell | 17 | 2019 | 935 | 2.520 |
Why?
|
Immunohistochemistry | 51 | 2020 | 11070 | 2.420 |
Why?
|
Tissue Fixation | 5 | 2024 | 241 | 2.220 |
Why?
|
Cells | 4 | 2020 | 164 | 2.110 |
Why?
|
Antibodies | 7 | 2022 | 2420 | 2.030 |
Why?
|
Tumor Microenvironment | 41 | 2024 | 3840 | 2.000 |
Why?
|
Proto-Oncogene Proteins c-myc | 11 | 2016 | 989 | 1.900 |
Why?
|
Paraffin Embedding | 5 | 2024 | 302 | 1.720 |
Why?
|
Mediastinal Neoplasms | 9 | 2019 | 402 | 1.550 |
Why?
|
Burkitt Lymphoma | 7 | 2022 | 333 | 1.530 |
Why?
|
Reed-Sternberg Cells | 9 | 2019 | 72 | 1.350 |
Why?
|
Lymphoproliferative Disorders | 8 | 2012 | 533 | 1.340 |
Why?
|
Antigens | 3 | 2022 | 1445 | 1.220 |
Why?
|
Cytological Techniques | 2 | 2019 | 218 | 1.160 |
Why?
|
Protein-Tyrosine Kinases | 16 | 2019 | 2416 | 1.130 |
Why?
|
Neoplasm Proteins | 9 | 2021 | 3609 | 1.040 |
Why?
|
Lung Neoplasms | 29 | 2024 | 13245 | 1.000 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 15 | 2020 | 1086 | 0.990 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 21 | 2024 | 5246 | 0.960 |
Why?
|
Chromosomes, Human, Pair 9 | 8 | 2019 | 534 | 0.900 |
Why?
|
Melanoma | 16 | 2023 | 5691 | 0.860 |
Why?
|
Tumor Escape | 3 | 2021 | 370 | 0.850 |
Why?
|
Leukemia, Myeloid, Acute | 13 | 2024 | 3599 | 0.840 |
Why?
|
Antibodies, Neoplasm | 5 | 2016 | 280 | 0.830 |
Why?
|
Antibodies, Monoclonal | 22 | 2023 | 9160 | 0.830 |
Why?
|
Lymphoma | 9 | 2022 | 1896 | 0.820 |
Why?
|
T-Lymphocytes | 19 | 2023 | 10171 | 0.790 |
Why?
|
Histiocytes | 2 | 2022 | 98 | 0.780 |
Why?
|
Histological Techniques | 2 | 2022 | 194 | 0.760 |
Why?
|
Lymphoma, T-Cell | 6 | 2018 | 304 | 0.760 |
Why?
|
Galectin 1 | 6 | 2017 | 128 | 0.750 |
Why?
|
Antigens, CD19 | 3 | 2021 | 424 | 0.750 |
Why?
|
Antigens, Neoplasm | 10 | 2022 | 1997 | 0.740 |
Why?
|
Frozen Sections | 2 | 2021 | 153 | 0.730 |
Why?
|
Histiocytosis, Langerhans-Cell | 2 | 2016 | 169 | 0.730 |
Why?
|
Polylysine | 1 | 2020 | 131 | 0.720 |
Why?
|
Galactosides | 1 | 2020 | 54 | 0.710 |
Why?
|
In Situ Hybridization, Fluorescence | 12 | 2016 | 2504 | 0.710 |
Why?
|
Immunoenzyme Techniques | 7 | 2020 | 1705 | 0.690 |
Why?
|
Gold Colloid | 1 | 2019 | 12 | 0.680 |
Why?
|
Histocytochemistry | 1 | 2020 | 700 | 0.670 |
Why?
|
CD8-Positive T-Lymphocytes | 19 | 2024 | 4549 | 0.670 |
Why?
|
Laminin | 1 | 2021 | 405 | 0.670 |
Why?
|
Lymphoma, Non-Hodgkin | 3 | 2023 | 1373 | 0.660 |
Why?
|
Receptor Protein-Tyrosine Kinases | 13 | 2014 | 1613 | 0.660 |
Why?
|
Horseradish Peroxidase | 1 | 2019 | 166 | 0.650 |
Why?
|
Humans | 288 | 2024 | 758406 | 0.650 |
Why?
|
beta-Galactosidase | 1 | 2020 | 574 | 0.650 |
Why?
|
Immunotherapy | 14 | 2023 | 4641 | 0.630 |
Why?
|
Gene Expression Regulation, Neoplastic | 26 | 2024 | 8506 | 0.610 |
Why?
|
Antineoplastic Agents | 28 | 2023 | 13591 | 0.610 |
Why?
|
Mutation | 46 | 2024 | 29915 | 0.600 |
Why?
|
Histiocytosis, Sinus | 2 | 2016 | 46 | 0.600 |
Why?
|
Indoles | 5 | 2020 | 1828 | 0.590 |
Why?
|
B-Lymphocytes | 18 | 2024 | 4738 | 0.590 |
Why?
|
Lymphoma, Follicular | 5 | 2023 | 453 | 0.590 |
Why?
|
Proteoglycans | 1 | 2021 | 801 | 0.590 |
Why?
|
Chromosome Aberrations | 6 | 2023 | 1763 | 0.590 |
Why?
|
Translocation, Genetic | 13 | 2016 | 1387 | 0.580 |
Why?
|
Proteins | 4 | 2023 | 6026 | 0.580 |
Why?
|
Cell Line, Tumor | 53 | 2021 | 16886 | 0.580 |
Why?
|
Bone Marrow | 8 | 2024 | 2909 | 0.570 |
Why?
|
Adenocarcinoma | 9 | 2023 | 6313 | 0.570 |
Why?
|
Microscopy, Fluorescence | 3 | 2021 | 2646 | 0.570 |
Why?
|
Drug Resistance, Neoplasm | 14 | 2020 | 5249 | 0.560 |
Why?
|
Antigens, Surface | 1 | 2021 | 1607 | 0.560 |
Why?
|
beta 2-Microglobulin | 2 | 2018 | 328 | 0.550 |
Why?
|
Lymphoma, Mantle-Cell | 5 | 2016 | 237 | 0.540 |
Why?
|
TNF Receptor-Associated Factor 1 | 2 | 2007 | 50 | 0.530 |
Why?
|
Polyomavirus Infections | 2 | 2022 | 194 | 0.530 |
Why?
|
Proto-Oncogene Proteins c-rel | 2 | 2007 | 71 | 0.530 |
Why?
|
Neoplasms | 22 | 2023 | 22032 | 0.530 |
Why?
|
Histiocytic Necrotizing Lymphadenitis | 1 | 2016 | 26 | 0.520 |
Why?
|
Pyrazoles | 9 | 2016 | 1988 | 0.520 |
Why?
|
Photography | 1 | 2019 | 530 | 0.520 |
Why?
|
Alkaline Phosphatase | 1 | 2019 | 865 | 0.520 |
Why?
|
Proto-Oncogene Proteins | 7 | 2013 | 4485 | 0.510 |
Why?
|
Iodine Radioisotopes | 1 | 2019 | 1032 | 0.510 |
Why?
|
Lymphoid Tissue | 3 | 2015 | 445 | 0.500 |
Why?
|
Fluorescent Antibody Technique | 8 | 2023 | 2470 | 0.500 |
Why?
|
Antibody Specificity | 2 | 2021 | 1060 | 0.500 |
Why?
|
Protein Kinase Inhibitors | 19 | 2017 | 5629 | 0.490 |
Why?
|
Pathology, Surgical | 1 | 2016 | 151 | 0.490 |
Why?
|
Cell Adhesion | 6 | 2020 | 3090 | 0.480 |
Why?
|
HLA Antigens | 3 | 2022 | 1368 | 0.480 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 22 | 2023 | 11709 | 0.470 |
Why?
|
Receptors, Antigen, T-Cell | 6 | 2020 | 2532 | 0.470 |
Why?
|
Collagen | 2 | 2021 | 2635 | 0.460 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2022 | 321 | 0.460 |
Why?
|
Gene Rearrangement | 7 | 2018 | 1122 | 0.450 |
Why?
|
Janus Kinase 2 | 8 | 2015 | 537 | 0.450 |
Why?
|
Transcription Factor AP-1 | 4 | 2012 | 321 | 0.450 |
Why?
|
Vulvar Neoplasms | 1 | 2016 | 263 | 0.440 |
Why?
|
Hematopoietic Stem Cell Transplantation | 12 | 2023 | 5649 | 0.440 |
Why?
|
Receptors, Antigen, B-Cell | 4 | 2023 | 545 | 0.440 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 1664 | 0.440 |
Why?
|
Oncogene Proteins, Fusion | 8 | 2016 | 1594 | 0.440 |
Why?
|
Fluorescent Dyes | 1 | 2021 | 1897 | 0.430 |
Why?
|
Gene Expression | 9 | 2016 | 7583 | 0.430 |
Why?
|
Coloring Agents | 3 | 2019 | 560 | 0.410 |
Why?
|
Animals | 91 | 2024 | 167768 | 0.410 |
Why?
|
Carcinoma, Squamous Cell | 5 | 2024 | 4023 | 0.400 |
Why?
|
Histocompatibility Antigens Class I | 3 | 2021 | 1355 | 0.400 |
Why?
|
Lymphoma, Large-Cell, Anaplastic | 3 | 2014 | 167 | 0.400 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2015 | 2872 | 0.390 |
Why?
|
Antigens, CD | 8 | 2014 | 3997 | 0.390 |
Why?
|
Microscopy | 3 | 2023 | 884 | 0.380 |
Why?
|
Genes, myc | 3 | 2013 | 391 | 0.380 |
Why?
|
Saccharomyces cerevisiae | 1 | 2022 | 2695 | 0.380 |
Why?
|
Pre-B Cell Receptors | 1 | 2010 | 3 | 0.370 |
Why?
|
Gene Expression Profiling | 21 | 2024 | 9404 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-met | 3 | 2012 | 567 | 0.370 |
Why?
|
Hematologic Neoplasms | 3 | 2023 | 1890 | 0.370 |
Why?
|
Immunophenotyping | 10 | 2024 | 1871 | 0.360 |
Why?
|
Sarcoidosis | 1 | 2016 | 520 | 0.360 |
Why?
|
Flow Cytometry | 16 | 2023 | 5864 | 0.350 |
Why?
|
Pyridines | 7 | 2014 | 2859 | 0.350 |
Why?
|
Gene Dosage | 5 | 2016 | 1218 | 0.350 |
Why?
|
Molecular Targeted Therapy | 7 | 2021 | 2796 | 0.340 |
Why?
|
Cytokines | 11 | 2019 | 7338 | 0.340 |
Why?
|
Protein Binding | 8 | 2021 | 9311 | 0.340 |
Why?
|
Tumor Virus Infections | 1 | 2012 | 438 | 0.340 |
Why?
|
Female | 124 | 2024 | 390323 | 0.340 |
Why?
|
Receptor, Notch1 | 2 | 2013 | 495 | 0.330 |
Why?
|
Myeloproliferative Disorders | 5 | 2023 | 606 | 0.330 |
Why?
|
Waldenstrom Macroglobulinemia | 6 | 2015 | 1067 | 0.330 |
Why?
|
Myelodysplastic Syndromes | 4 | 2023 | 1392 | 0.320 |
Why?
|
Pyrimidines | 6 | 2021 | 3006 | 0.320 |
Why?
|
Receptors, Cytokine | 3 | 2012 | 258 | 0.320 |
Why?
|
Karyopherins | 3 | 2015 | 130 | 0.320 |
Why?
|
Skin Neoplasms | 7 | 2023 | 5797 | 0.320 |
Why?
|
Middle Aged | 83 | 2024 | 219568 | 0.320 |
Why?
|
Silver | 2 | 2019 | 116 | 0.320 |
Why?
|
Formaldehyde | 3 | 2024 | 358 | 0.320 |
Why?
|
Intestinal Neoplasms | 2 | 2023 | 311 | 0.320 |
Why?
|
Nuclear Proteins | 13 | 2023 | 5786 | 0.310 |
Why?
|
Aged | 70 | 2024 | 168218 | 0.310 |
Why?
|
Angiopoietin-2 | 2 | 2021 | 172 | 0.310 |
Why?
|
Amino Acid Substitution | 2 | 2016 | 1734 | 0.310 |
Why?
|
Male | 110 | 2024 | 358747 | 0.310 |
Why?
|
Neoplasm Staging | 19 | 2021 | 11152 | 0.300 |
Why?
|
Neoplasm Recurrence, Local | 10 | 2023 | 9273 | 0.300 |
Why?
|
Neurofibromin 1 | 2 | 2021 | 190 | 0.290 |
Why?
|
Macrophages | 11 | 2024 | 5737 | 0.290 |
Why?
|
Bone Marrow Examination | 4 | 2015 | 154 | 0.290 |
Why?
|
Prognosis | 27 | 2024 | 29557 | 0.290 |
Why?
|
Mice | 68 | 2024 | 81101 | 0.290 |
Why?
|
Cells, Cultured | 8 | 2021 | 18940 | 0.290 |
Why?
|
Cancer Vaccines | 3 | 2021 | 1046 | 0.290 |
Why?
|
Lymphocytes | 4 | 2021 | 2610 | 0.280 |
Why?
|
Interferon-gamma | 9 | 2020 | 3156 | 0.280 |
Why?
|
Signal Transduction | 29 | 2023 | 23342 | 0.280 |
Why?
|
Aged, 80 and over | 37 | 2024 | 58683 | 0.280 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 1 | 2008 | 164 | 0.280 |
Why?
|
Hydroxamic Acids | 3 | 2016 | 481 | 0.280 |
Why?
|
Dendritic Cells | 3 | 2023 | 2723 | 0.280 |
Why?
|
Glioblastoma | 5 | 2023 | 3480 | 0.280 |
Why?
|
Xenograft Model Antitumor Assays | 17 | 2021 | 3574 | 0.280 |
Why?
|
BRCA1 Protein | 5 | 2020 | 1147 | 0.270 |
Why?
|
Germinal Center | 5 | 2012 | 378 | 0.270 |
Why?
|
Substrate Specificity | 3 | 2020 | 1792 | 0.270 |
Why?
|
B-Lymphocyte Subsets | 4 | 2012 | 241 | 0.270 |
Why?
|
Spleen | 7 | 2012 | 2296 | 0.260 |
Why?
|
Myeloid Differentiation Factor 88 | 3 | 2023 | 581 | 0.260 |
Why?
|
Mouth Neoplasms | 2 | 2022 | 593 | 0.260 |
Why?
|
Lymphocyte Subsets | 2 | 2019 | 310 | 0.260 |
Why?
|
Stomach Neoplasms | 3 | 2023 | 1422 | 0.260 |
Why?
|
Adult | 69 | 2024 | 219935 | 0.260 |
Why?
|
Leukemia, Myeloid | 2 | 2021 | 695 | 0.260 |
Why?
|
Proto-Oncogene Proteins c-akt | 7 | 2014 | 2443 | 0.260 |
Why?
|
Receptors, Interleukin-4 | 1 | 2005 | 64 | 0.260 |
Why?
|
T-Lymphocytes, Regulatory | 7 | 2023 | 3071 | 0.260 |
Why?
|
Head and Neck Neoplasms | 4 | 2024 | 2882 | 0.260 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2012 | 929 | 0.250 |
Why?
|
Cell Proliferation | 23 | 2021 | 10416 | 0.250 |
Why?
|
Membrane Glycoproteins | 3 | 2010 | 3705 | 0.250 |
Why?
|
Mutation, Missense | 3 | 2023 | 2564 | 0.250 |
Why?
|
Interferons | 3 | 2020 | 705 | 0.250 |
Why?
|
Genomics | 10 | 2024 | 5790 | 0.250 |
Why?
|
Gene Amplification | 5 | 2020 | 1085 | 0.240 |
Why?
|
Multiple Myeloma | 9 | 2016 | 5129 | 0.240 |
Why?
|
Triazoles | 4 | 2015 | 902 | 0.240 |
Why?
|
Salvage Therapy | 4 | 2021 | 1268 | 0.240 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 3 | 2015 | 855 | 0.240 |
Why?
|
Molecular Diagnostic Techniques | 3 | 2015 | 611 | 0.240 |
Why?
|
Reticulin | 2 | 2014 | 19 | 0.240 |
Why?
|
Neuroendocrine Tumors | 2 | 2023 | 650 | 0.240 |
Why?
|
Histone Deacetylase Inhibitors | 3 | 2016 | 772 | 0.240 |
Why?
|
CD4-Positive T-Lymphocytes | 6 | 2022 | 4353 | 0.240 |
Why?
|
Histocompatibility Antigens Class II | 3 | 2018 | 1446 | 0.240 |
Why?
|
Lymphocyte Activation | 11 | 2020 | 5490 | 0.230 |
Why?
|
Epitopes | 2 | 2021 | 2502 | 0.230 |
Why?
|
Biopsy | 9 | 2016 | 6768 | 0.230 |
Why?
|
Pleural Neoplasms | 3 | 2016 | 609 | 0.230 |
Why?
|
Cell Cycle | 7 | 2016 | 2930 | 0.230 |
Why?
|
Zebrafish | 6 | 2021 | 2993 | 0.230 |
Why?
|
Oncogenes | 4 | 2013 | 1220 | 0.220 |
Why?
|
Uterine Cervical Neoplasms | 1 | 2016 | 2016 | 0.220 |
Why?
|
Cell Nucleus | 4 | 2013 | 2907 | 0.220 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2017 | 655 | 0.220 |
Why?
|
Fourier Analysis | 1 | 2024 | 439 | 0.220 |
Why?
|
Carcinoma, Adenoid Cystic | 2 | 2016 | 262 | 0.220 |
Why?
|
PTEN Phosphohydrolase | 2 | 2021 | 1113 | 0.220 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2021 | 419 | 0.220 |
Why?
|
Biological Products | 3 | 2021 | 906 | 0.220 |
Why?
|
Protein Isoforms | 3 | 2017 | 1694 | 0.220 |
Why?
|
Observer Variation | 4 | 2016 | 2600 | 0.220 |
Why?
|
Herpesvirus 4, Human | 4 | 2013 | 1075 | 0.220 |
Why?
|
HSP90 Heat-Shock Proteins | 3 | 2016 | 423 | 0.210 |
Why?
|
Leiomyosarcoma | 2 | 2017 | 424 | 0.210 |
Why?
|
Mesothelioma | 3 | 2016 | 807 | 0.210 |
Why?
|
Enzyme Activation | 7 | 2015 | 3593 | 0.210 |
Why?
|
Spheroplasts | 1 | 2022 | 6 | 0.210 |
Why?
|
Carcinoma | 3 | 2023 | 2330 | 0.210 |
Why?
|
Boronic Acids | 3 | 2012 | 914 | 0.210 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2023 | 117 | 0.210 |
Why?
|
Janus Kinase 3 | 2 | 2015 | 77 | 0.200 |
Why?
|
Epstein-Barr Virus Infections | 3 | 2016 | 608 | 0.200 |
Why?
|
Immunomodulation | 2 | 2016 | 545 | 0.200 |
Why?
|
Specimen Handling | 2 | 2020 | 707 | 0.200 |
Why?
|
Receptors, CXCR4 | 4 | 2019 | 727 | 0.200 |
Why?
|
Mice, SCID | 11 | 2016 | 2626 | 0.200 |
Why?
|
Nocardia Infections | 1 | 2001 | 19 | 0.200 |
Why?
|
Angiomyolipoma | 1 | 2023 | 184 | 0.200 |
Why?
|
Gastrointestinal Neoplasms | 2 | 2023 | 951 | 0.200 |
Why?
|
Chemotaxis, Leukocyte | 3 | 2019 | 663 | 0.200 |
Why?
|
NF-kappa B | 4 | 2015 | 2472 | 0.190 |
Why?
|
Bone Marrow Cells | 6 | 2015 | 2414 | 0.190 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2016 | 2825 | 0.190 |
Why?
|
Xanthenes | 1 | 2021 | 72 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 3 | 2016 | 191 | 0.190 |
Why?
|
Immunotherapy, Adoptive | 3 | 2020 | 1454 | 0.190 |
Why?
|
Sulfonamides | 4 | 2021 | 1973 | 0.190 |
Why?
|
Enhancer Elements, Genetic | 4 | 2016 | 1356 | 0.190 |
Why?
|
Antigen-Antibody Reactions | 1 | 2021 | 346 | 0.190 |
Why?
|
Pyrazines | 3 | 2012 | 1198 | 0.190 |
Why?
|
Recurrence | 12 | 2023 | 8426 | 0.190 |
Why?
|
Splenic Diseases | 1 | 2001 | 90 | 0.190 |
Why?
|
Reproducibility of Results | 7 | 2023 | 20055 | 0.190 |
Why?
|
Sirolimus | 6 | 2021 | 1533 | 0.190 |
Why?
|
Blotting, Western | 9 | 2019 | 5031 | 0.180 |
Why?
|
Gene Expression Regulation, Leukemic | 3 | 2021 | 646 | 0.180 |
Why?
|
Microsatellite Instability | 4 | 2020 | 715 | 0.180 |
Why?
|
Rhodamines | 1 | 2021 | 178 | 0.180 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2019 | 2858 | 0.180 |
Why?
|
Fluorescein | 1 | 2021 | 174 | 0.180 |
Why?
|
Centrifugation | 1 | 2020 | 122 | 0.180 |
Why?
|
Zebrafish Proteins | 2 | 2019 | 1006 | 0.180 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2016 | 2912 | 0.180 |
Why?
|
Glutaral | 1 | 2020 | 76 | 0.180 |
Why?
|
Pyridinium Compounds | 2 | 2017 | 81 | 0.180 |
Why?
|
Immunoglobulins | 3 | 2019 | 859 | 0.180 |
Why?
|
Diagnosis, Differential | 8 | 2019 | 12951 | 0.180 |
Why?
|
Genes, p53 | 2 | 2013 | 712 | 0.180 |
Why?
|
Neoplasms, Muscle Tissue | 2 | 2010 | 67 | 0.170 |
Why?
|
Pancreatic Neoplasms | 3 | 2023 | 5349 | 0.170 |
Why?
|
Trans-Activators | 6 | 2019 | 2860 | 0.170 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2022 | 1725 | 0.170 |
Why?
|
Testicular Neoplasms | 2 | 2017 | 801 | 0.170 |
Why?
|
DNA Mutational Analysis | 6 | 2020 | 4106 | 0.170 |
Why?
|
Anus Neoplasms | 1 | 2024 | 329 | 0.170 |
Why?
|
Calorimetry | 1 | 2020 | 129 | 0.170 |
Why?
|
Stem Cell Transplantation | 3 | 2017 | 1599 | 0.170 |
Why?
|
Neoplastic Stem Cells | 3 | 2018 | 1346 | 0.170 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2014 | 381 | 0.170 |
Why?
|
Mice, Inbred NOD | 9 | 2016 | 1825 | 0.170 |
Why?
|
3,3'-Diaminobenzidine | 1 | 2019 | 5 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 8 | 2021 | 6493 | 0.170 |
Why?
|
Indicators and Reagents | 1 | 2020 | 460 | 0.170 |
Why?
|
Chromogenic Compounds | 1 | 2019 | 31 | 0.170 |
Why?
|
Receptors, Chemokine | 1 | 2002 | 655 | 0.170 |
Why?
|
Phosphorylcholine | 2 | 2010 | 153 | 0.170 |
Why?
|
Cell Survival | 8 | 2021 | 5781 | 0.170 |
Why?
|
Oncolytic Viruses | 1 | 2023 | 343 | 0.170 |
Why?
|
Benzimidazoles | 3 | 2015 | 855 | 0.170 |
Why?
|
Neoplasm, Residual | 3 | 2016 | 1007 | 0.170 |
Why?
|
Neoadjuvant Therapy | 5 | 2023 | 2821 | 0.170 |
Why?
|
Nucleic Acids | 1 | 2022 | 187 | 0.170 |
Why?
|
Tissue Culture Techniques | 1 | 2020 | 290 | 0.160 |
Why?
|
Predictive Value of Tests | 8 | 2018 | 15225 | 0.160 |
Why?
|
Pathology, Molecular | 1 | 2022 | 328 | 0.160 |
Why?
|
Neoplasm Metastasis | 10 | 2022 | 4901 | 0.160 |
Why?
|
Up-Regulation | 6 | 2019 | 4113 | 0.160 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2013 | 1134 | 0.160 |
Why?
|
Glycoproteins | 1 | 2006 | 2205 | 0.160 |
Why?
|
Pyrrolidines | 3 | 2015 | 337 | 0.160 |
Why?
|
Colorectal Neoplasms | 4 | 2021 | 6852 | 0.160 |
Why?
|
Phenotype | 8 | 2024 | 16534 | 0.160 |
Why?
|
Cytophotometry | 1 | 2018 | 8 | 0.160 |
Why?
|
Survival Analysis | 7 | 2023 | 10112 | 0.160 |
Why?
|
Cyclin D1 | 2 | 2013 | 451 | 0.160 |
Why?
|
Killer Cells, Natural | 4 | 2022 | 2201 | 0.160 |
Why?
|
Genes, Tumor Suppressor | 2 | 2013 | 1055 | 0.160 |
Why?
|
DNA Copy Number Variations | 6 | 2019 | 2012 | 0.160 |
Why?
|
Bone Marrow Neoplasms | 1 | 2019 | 101 | 0.160 |
Why?
|
Antibodies, Blocking | 1 | 2019 | 242 | 0.150 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2017 | 1627 | 0.150 |
Why?
|
Tissue Array Analysis | 4 | 2012 | 551 | 0.150 |
Why?
|
Receptors, Interferon | 1 | 1998 | 116 | 0.150 |
Why?
|
Enteropathy-Associated T-Cell Lymphoma | 2 | 2014 | 13 | 0.150 |
Why?
|
High-Throughput Nucleotide Sequencing | 7 | 2022 | 3615 | 0.150 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2010 | 223 | 0.150 |
Why?
|
Immune Evasion | 2 | 2019 | 362 | 0.150 |
Why?
|
Forkhead Transcription Factors | 6 | 2022 | 1611 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-jun | 2 | 2009 | 285 | 0.150 |
Why?
|
Cell Movement | 6 | 2013 | 5201 | 0.150 |
Why?
|
Herpesvirus 1, Human | 1 | 2023 | 753 | 0.150 |
Why?
|
Uterine Neoplasms | 2 | 2017 | 1439 | 0.150 |
Why?
|
Central Nervous System Neoplasms | 2 | 2017 | 916 | 0.150 |
Why?
|
Leukemia, Lymphoid | 1 | 2018 | 310 | 0.150 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 1 | 2022 | 538 | 0.150 |
Why?
|
Oncolytic Virotherapy | 1 | 2023 | 515 | 0.150 |
Why?
|
Tumor Cells, Cultured | 8 | 2022 | 6127 | 0.150 |
Why?
|
Immunoconjugates | 3 | 2016 | 949 | 0.150 |
Why?
|
Genetic Heterogeneity | 3 | 2018 | 723 | 0.150 |
Why?
|
Cell Lineage | 5 | 2016 | 2533 | 0.150 |
Why?
|
Apoptosis | 16 | 2022 | 9468 | 0.150 |
Why?
|
Transcription, Genetic | 7 | 2018 | 7590 | 0.150 |
Why?
|
Melanoma, Experimental | 2 | 2019 | 559 | 0.150 |
Why?
|
Phosphorylation | 6 | 2015 | 8297 | 0.150 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 7 | 2015 | 4567 | 0.150 |
Why?
|
Histones | 4 | 2023 | 2577 | 0.140 |
Why?
|
Survival Rate | 13 | 2020 | 12721 | 0.140 |
Why?
|
Carcinoma, Renal Cell | 2 | 2023 | 3217 | 0.140 |
Why?
|
Disease Models, Animal | 13 | 2021 | 18119 | 0.140 |
Why?
|
Treatment Outcome | 28 | 2023 | 64378 | 0.140 |
Why?
|
Ovarian Neoplasms | 3 | 2020 | 4876 | 0.140 |
Why?
|
Endogenous Retroviruses | 1 | 2018 | 111 | 0.140 |
Why?
|
Molecular Imaging | 2 | 2022 | 815 | 0.140 |
Why?
|
Immunoblastic Lymphadenopathy | 2 | 2014 | 40 | 0.140 |
Why?
|
Cohort Studies | 18 | 2022 | 41256 | 0.140 |
Why?
|
Thiophenes | 1 | 2021 | 569 | 0.140 |
Why?
|
Simian immunodeficiency virus | 1 | 2022 | 805 | 0.140 |
Why?
|
Acetylcysteine | 2 | 2016 | 261 | 0.140 |
Why?
|
Brain Neoplasms | 3 | 2024 | 8981 | 0.140 |
Why?
|
Embryo, Nonmammalian | 2 | 2019 | 900 | 0.140 |
Why?
|
Resorcinols | 1 | 2016 | 41 | 0.140 |
Why?
|
Estrogen Receptor alpha | 2 | 2019 | 580 | 0.140 |
Why?
|
Immunity | 3 | 2018 | 998 | 0.130 |
Why?
|
Primary Myelofibrosis | 2 | 2015 | 208 | 0.130 |
Why?
|
Immunologic Memory | 2 | 2021 | 1353 | 0.130 |
Why?
|
Viral Matrix Proteins | 3 | 2012 | 196 | 0.130 |
Why?
|
Transplantation, Autologous | 5 | 2020 | 2114 | 0.130 |
Why?
|
Th17 Cells | 1 | 2023 | 785 | 0.130 |
Why?
|
Oncogene Proteins v-myb | 1 | 2016 | 25 | 0.130 |
Why?
|
Immunity, Innate | 2 | 2018 | 3047 | 0.130 |
Why?
|
Microsatellite Repeats | 1 | 2018 | 785 | 0.130 |
Why?
|
DNA Mismatch Repair | 1 | 2019 | 428 | 0.130 |
Why?
|
DNA-Binding Proteins | 10 | 2015 | 9574 | 0.130 |
Why?
|
Interleukin-2 | 2 | 2022 | 1888 | 0.130 |
Why?
|
Vascular Endothelial Growth Factor A | 3 | 2017 | 3480 | 0.130 |
Why?
|
Ribosomal Proteins | 2 | 2016 | 363 | 0.130 |
Why?
|
Kidney Neoplasms | 2 | 2023 | 4312 | 0.130 |
Why?
|
Autoimmunity | 2 | 2016 | 1358 | 0.130 |
Why?
|
Breast Neoplasms | 10 | 2021 | 21017 | 0.130 |
Why?
|
Virus Diseases | 1 | 2022 | 719 | 0.130 |
Why?
|
Vincristine | 2 | 2016 | 1038 | 0.130 |
Why?
|
Islets of Langerhans Transplantation | 2 | 2010 | 738 | 0.130 |
Why?
|
Disease-Free Survival | 8 | 2019 | 6821 | 0.130 |
Why?
|
Biopsy, Needle | 1 | 2020 | 1630 | 0.130 |
Why?
|
Transcription Factors | 7 | 2021 | 12094 | 0.130 |
Why?
|
Neoplastic Cells, Circulating | 2 | 2013 | 938 | 0.130 |
Why?
|
Cell Differentiation | 11 | 2023 | 11471 | 0.130 |
Why?
|
Neuroblastoma | 3 | 2012 | 1251 | 0.130 |
Why?
|
Gene Rearrangement, T-Lymphocyte | 1 | 2015 | 111 | 0.130 |
Why?
|
Retrospective Studies | 20 | 2024 | 80168 | 0.130 |
Why?
|
U937 Cells | 1 | 2015 | 262 | 0.120 |
Why?
|
Polymerase Chain Reaction | 4 | 2015 | 6068 | 0.120 |
Why?
|
Repressor Proteins | 2 | 2019 | 2980 | 0.120 |
Why?
|
DNA Polymerase II | 1 | 2015 | 104 | 0.120 |
Why?
|
Pseudogenes | 1 | 2015 | 103 | 0.120 |
Why?
|
Paraffin | 1 | 2014 | 37 | 0.120 |
Why?
|
Single-Cell Analysis | 3 | 2021 | 2379 | 0.120 |
Why?
|
Receptors, Laminin | 1 | 2014 | 26 | 0.120 |
Why?
|
Lymphoma, T-Cell, Cutaneous | 2 | 2015 | 209 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2017 | 10748 | 0.120 |
Why?
|
GTP-Binding Protein beta Subunits | 1 | 2014 | 33 | 0.120 |
Why?
|
Diagnostic Imaging | 3 | 2024 | 3526 | 0.120 |
Why?
|
Dioxygenases | 2 | 2014 | 332 | 0.120 |
Why?
|
Isoxazoles | 1 | 2016 | 230 | 0.120 |
Why?
|
HL-60 Cells | 1 | 2015 | 363 | 0.120 |
Why?
|
Drug Combinations | 1 | 2021 | 2020 | 0.120 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2015 | 1547 | 0.120 |
Why?
|
Young Adult | 19 | 2022 | 58808 | 0.120 |
Why?
|
Disease Progression | 14 | 2019 | 13468 | 0.120 |
Why?
|
DNA, Bacterial | 2 | 2017 | 1456 | 0.120 |
Why?
|
Leukemia, T-Cell | 1 | 2014 | 101 | 0.120 |
Why?
|
Immunoglobulin Light Chains | 1 | 2015 | 286 | 0.120 |
Why?
|
Transcription Factor RelA | 1 | 2015 | 250 | 0.120 |
Why?
|
Antigen Presentation | 2 | 2018 | 1254 | 0.120 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2016 | 367 | 0.120 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 2 | 2014 | 693 | 0.120 |
Why?
|
Hot Temperature | 1 | 2021 | 1434 | 0.120 |
Why?
|
Transplantation, Homologous | 7 | 2022 | 4809 | 0.120 |
Why?
|
Integrin alpha Chains | 1 | 2014 | 95 | 0.120 |
Why?
|
Receptors, Progesterone | 1 | 2019 | 1130 | 0.120 |
Why?
|
Active Transport, Cell Nucleus | 2 | 2013 | 435 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2021 | 1404 | 0.120 |
Why?
|
Palatine Tonsil | 2 | 2024 | 193 | 0.110 |
Why?
|
Lymphoma, Extranodal NK-T-Cell | 1 | 2014 | 45 | 0.110 |
Why?
|
Combined Modality Therapy | 4 | 2022 | 8530 | 0.110 |
Why?
|
Mice, Inbred C57BL | 16 | 2019 | 22003 | 0.110 |
Why?
|
Azepines | 2 | 2013 | 329 | 0.110 |
Why?
|
Proteomics | 2 | 2024 | 3816 | 0.110 |
Why?
|
BRCA2 Protein | 2 | 2016 | 798 | 0.110 |
Why?
|
Hydrazines | 1 | 2015 | 224 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-bcr | 1 | 2013 | 19 | 0.110 |
Why?
|
Pneumonia | 2 | 2023 | 2129 | 0.110 |
Why?
|
Quinazolines | 4 | 2013 | 1360 | 0.110 |
Why?
|
Drug Synergism | 5 | 2021 | 1745 | 0.110 |
Why?
|
Protein Processing, Post-Translational | 2 | 2012 | 1972 | 0.110 |
Why?
|
Prednisone | 2 | 2016 | 1565 | 0.110 |
Why?
|
T-Lymphocyte Subsets | 3 | 2010 | 1807 | 0.110 |
Why?
|
Receptors, Immunologic | 3 | 2020 | 1411 | 0.110 |
Why?
|
Polymers | 1 | 2020 | 1616 | 0.110 |
Why?
|
Oxygen | 2 | 2015 | 4191 | 0.110 |
Why?
|
Nuclear Export Signals | 1 | 2012 | 9 | 0.110 |
Why?
|
Adenosine | 2 | 2015 | 802 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2001 | 0.110 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2020 | 3339 | 0.110 |
Why?
|
Cell Transformation, Viral | 2 | 2012 | 526 | 0.110 |
Why?
|
Receptors, Interleukin-7 | 1 | 2012 | 40 | 0.100 |
Why?
|
ran GTP-Binding Protein | 1 | 2012 | 51 | 0.100 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2014 | 124 | 0.100 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2018 | 491 | 0.100 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2023 | 1724 | 0.100 |
Why?
|
Intestine, Small | 1 | 2018 | 1207 | 0.100 |
Why?
|
Lymph Nodes | 4 | 2024 | 3485 | 0.100 |
Why?
|
Carcinoma, Transitional Cell | 1 | 2019 | 800 | 0.100 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2016 | 633 | 0.100 |
Why?
|
Receptors, Lysosphingolipid | 1 | 2013 | 121 | 0.100 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2014 | 179 | 0.100 |
Why?
|
Cell Cycle Proteins | 5 | 2016 | 3442 | 0.100 |
Why?
|
Lymphoma, Large-Cell, Immunoblastic | 1 | 2011 | 25 | 0.100 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2001 | 1214 | 0.100 |
Why?
|
Retinol-Binding Proteins, Cellular | 1 | 2011 | 12 | 0.100 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 2012 | 257 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1612 | 0.100 |
Why?
|
Retinoblastoma Protein | 2 | 2015 | 670 | 0.100 |
Why?
|
Fetal Proteins | 1 | 2012 | 97 | 0.100 |
Why?
|
Dexamethasone | 2 | 2018 | 1927 | 0.100 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2012 | 426 | 0.100 |
Why?
|
Mucous Membrane | 1 | 2015 | 656 | 0.100 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2016 | 1765 | 0.100 |
Why?
|
Antigen-Presenting Cells | 3 | 2022 | 964 | 0.100 |
Why?
|
Interleukin-4 Receptor alpha Subunit | 1 | 2012 | 57 | 0.100 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 614 | 0.100 |
Why?
|
Cystadenocarcinoma, Serous | 1 | 2016 | 479 | 0.100 |
Why?
|
Autocrine Communication | 1 | 2012 | 169 | 0.100 |
Why?
|
Receptors, Virus | 2 | 2016 | 639 | 0.100 |
Why?
|
Genetic Fitness | 1 | 2012 | 115 | 0.100 |
Why?
|
Immunologic Surveillance | 1 | 2012 | 92 | 0.100 |
Why?
|
Aminopyridines | 1 | 2015 | 564 | 0.100 |
Why?
|
Haploinsufficiency | 1 | 2013 | 327 | 0.100 |
Why?
|
Doxorubicin | 2 | 2016 | 2209 | 0.100 |
Why?
|
Mice, Knockout | 12 | 2015 | 14354 | 0.090 |
Why?
|
Herpesvirus 8, Human | 1 | 2013 | 255 | 0.090 |
Why?
|
Plasmacytoma | 1 | 2012 | 171 | 0.090 |
Why?
|
Fibrosis | 2 | 2015 | 2038 | 0.090 |
Why?
|
Barrett Esophagus | 1 | 2015 | 490 | 0.090 |
Why?
|
Neovascularization, Pathologic | 4 | 2016 | 2638 | 0.090 |
Why?
|
DNA, Neoplasm | 1 | 2016 | 1745 | 0.090 |
Why?
|
Neurilemmoma | 1 | 2016 | 523 | 0.090 |
Why?
|
Sp1 Transcription Factor | 1 | 2011 | 140 | 0.090 |
Why?
|
Adaptive Immunity | 1 | 2016 | 726 | 0.090 |
Why?
|
YY1 Transcription Factor | 1 | 2011 | 59 | 0.090 |
Why?
|
Anemia, Aplastic | 1 | 2013 | 228 | 0.090 |
Why?
|
Receptor, erbB-2 | 2 | 2019 | 2553 | 0.090 |
Why?
|
Self Tolerance | 1 | 2011 | 124 | 0.090 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 611 | 0.090 |
Why?
|
Gene Expression Regulation | 6 | 2014 | 11892 | 0.090 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2013 | 243 | 0.090 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2024 | 374 | 0.090 |
Why?
|
Mice, Inbred BALB C | 7 | 2015 | 6209 | 0.090 |
Why?
|
Ligands | 4 | 2022 | 3258 | 0.090 |
Why?
|
CDC2 Protein Kinase | 1 | 2011 | 213 | 0.090 |
Why?
|
Urologic Neoplasms | 1 | 2014 | 320 | 0.090 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2013 | 507 | 0.090 |
Why?
|
GTP-Binding Proteins | 1 | 2014 | 950 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 3 | 2018 | 2800 | 0.090 |
Why?
|
Clone Cells | 2 | 2011 | 1660 | 0.090 |
Why?
|
Adolescent | 12 | 2024 | 87892 | 0.090 |
Why?
|
Western World | 1 | 2009 | 27 | 0.090 |
Why?
|
Tissue Adhesions | 1 | 2011 | 222 | 0.090 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2010 | 85 | 0.090 |
Why?
|
Granuloma, Plasma Cell | 1 | 2010 | 80 | 0.090 |
Why?
|
src-Family Kinases | 1 | 2012 | 535 | 0.090 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2012 | 503 | 0.090 |
Why?
|
Gene Library | 1 | 2012 | 1059 | 0.090 |
Why?
|
Cytosine | 1 | 2011 | 210 | 0.080 |
Why?
|
Cell Tracking | 1 | 2011 | 138 | 0.080 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2010 | 131 | 0.080 |
Why?
|
Thalidomide | 2 | 2014 | 884 | 0.080 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2010 | 410 | 0.080 |
Why?
|
Clinical Trials as Topic | 3 | 2020 | 7985 | 0.080 |
Why?
|
Sensitivity and Specificity | 4 | 2015 | 14641 | 0.080 |
Why?
|
Mice, Nude | 4 | 2019 | 3602 | 0.080 |
Why?
|
Meninges | 1 | 2011 | 197 | 0.080 |
Why?
|
Remission Induction | 4 | 2019 | 2388 | 0.080 |
Why?
|
Antigens, Differentiation | 1 | 2012 | 911 | 0.080 |
Why?
|
Abdominal Neoplasms | 1 | 2010 | 286 | 0.080 |
Why?
|
RecQ Helicases | 1 | 2009 | 53 | 0.080 |
Why?
|
Genetic Loci | 2 | 2015 | 2612 | 0.080 |
Why?
|
Gene Silencing | 2 | 2013 | 1507 | 0.080 |
Why?
|
Microarray Analysis | 1 | 2012 | 746 | 0.080 |
Why?
|
Neutrophils | 1 | 2021 | 3765 | 0.080 |
Why?
|
TRPC Cation Channels | 1 | 2009 | 110 | 0.080 |
Why?
|
Cyclophosphamide | 1 | 2014 | 2218 | 0.080 |
Why?
|
Urea | 1 | 2011 | 444 | 0.080 |
Why?
|
Cytogenetic Analysis | 1 | 2009 | 270 | 0.080 |
Why?
|
Transcriptional Activation | 2 | 2012 | 1752 | 0.080 |
Why?
|
Chemokine CXCL12 | 1 | 2010 | 454 | 0.080 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2011 | 354 | 0.080 |
Why?
|
Gene Targeting | 2 | 2010 | 837 | 0.080 |
Why?
|
Breast | 2 | 2015 | 1963 | 0.080 |
Why?
|
Base Sequence | 6 | 2019 | 12436 | 0.080 |
Why?
|
Lymphopoiesis | 1 | 2009 | 133 | 0.080 |
Why?
|
Lipocalins | 1 | 2009 | 161 | 0.080 |
Why?
|
Piperidines | 4 | 2020 | 1639 | 0.080 |
Why?
|
Reproduction | 1 | 2012 | 646 | 0.080 |
Why?
|
Tumor Burden | 4 | 2015 | 1893 | 0.070 |
Why?
|
Polychlorinated Biphenyls | 1 | 2010 | 236 | 0.070 |
Why?
|
Oncogene Proteins | 1 | 2012 | 719 | 0.070 |
Why?
|
Acute-Phase Proteins | 1 | 2009 | 250 | 0.070 |
Why?
|
Base Pairing | 1 | 2008 | 140 | 0.070 |
Why?
|
Lectins, C-Type | 1 | 2011 | 585 | 0.070 |
Why?
|
Oocytes | 1 | 2012 | 1165 | 0.070 |
Why?
|
Epithelial Cells | 3 | 2022 | 3664 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4313 | 0.070 |
Why?
|
Immunoglobulin Heavy Chains | 2 | 2009 | 649 | 0.070 |
Why?
|
Indolizines | 2 | 2017 | 30 | 0.070 |
Why?
|
Drug Administration Schedule | 4 | 2017 | 4839 | 0.070 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2010 | 300 | 0.070 |
Why?
|
Cyclic N-Oxides | 2 | 2017 | 72 | 0.070 |
Why?
|
Mice, Transgenic | 7 | 2013 | 9518 | 0.070 |
Why?
|
Histone Deacetylases | 1 | 2012 | 718 | 0.070 |
Why?
|
Rectal Neoplasms | 1 | 2016 | 1152 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 2 | 2022 | 3733 | 0.070 |
Why?
|
Glioma | 1 | 2022 | 3418 | 0.070 |
Why?
|
Blood Vessels | 1 | 2012 | 1112 | 0.070 |
Why?
|
Cell Line | 7 | 2019 | 15591 | 0.070 |
Why?
|
Protein Transport | 1 | 2012 | 1963 | 0.070 |
Why?
|
Liposarcoma | 1 | 2009 | 283 | 0.070 |
Why?
|
Phosphoproteins | 2 | 2012 | 2433 | 0.070 |
Why?
|
Papillomaviridae | 2 | 2024 | 1120 | 0.070 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2019 | 2276 | 0.070 |
Why?
|
Genotype | 4 | 2015 | 12945 | 0.070 |
Why?
|
Cadherins | 1 | 2011 | 898 | 0.070 |
Why?
|
Endometrial Neoplasms | 1 | 2015 | 1357 | 0.070 |
Why?
|
Myeloid Cells | 1 | 2011 | 820 | 0.070 |
Why?
|
Chemokines | 2 | 2023 | 961 | 0.070 |
Why?
|
Meningioma | 1 | 2015 | 1217 | 0.070 |
Why?
|
Cell Membrane | 1 | 2015 | 3680 | 0.070 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2006 | 286 | 0.070 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 2 | 2022 | 666 | 0.070 |
Why?
|
Diabetes Mellitus, Type 1 | 3 | 2010 | 3432 | 0.070 |
Why?
|
Integrins | 1 | 2010 | 836 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinase | 2 | 2019 | 126 | 0.070 |
Why?
|
Tissue Distribution | 3 | 2017 | 2262 | 0.060 |
Why?
|
Molecular Sequence Data | 7 | 2015 | 17617 | 0.060 |
Why?
|
Meningeal Neoplasms | 1 | 2015 | 1247 | 0.060 |
Why?
|
Fusobacterium nucleatum | 2 | 2017 | 165 | 0.060 |
Why?
|
RNA-Binding Proteins | 2 | 2011 | 1894 | 0.060 |
Why?
|
Cytoplasm | 1 | 2010 | 1514 | 0.060 |
Why?
|
Adenine | 3 | 2016 | 975 | 0.060 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2010 | 1335 | 0.060 |
Why?
|
DNA | 2 | 2024 | 7199 | 0.060 |
Why?
|
Aspirin | 1 | 2017 | 3131 | 0.060 |
Why?
|
HIV Infections | 3 | 2022 | 17275 | 0.060 |
Why?
|
Multiple Sclerosis | 2 | 2011 | 3204 | 0.060 |
Why?
|
Genes, Neoplasm | 2 | 2018 | 370 | 0.060 |
Why?
|
Microtubule-Associated Proteins | 1 | 2010 | 1074 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2015 | 2053 | 0.060 |
Why?
|
RNA | 1 | 2015 | 2716 | 0.060 |
Why?
|
Genetic Variation | 3 | 2016 | 6548 | 0.060 |
Why?
|
Esophageal Neoplasms | 1 | 2015 | 1648 | 0.060 |
Why?
|
Anemia | 2 | 2012 | 1504 | 0.060 |
Why?
|
Retreatment | 2 | 2016 | 596 | 0.060 |
Why?
|
Dietary Fats | 1 | 2012 | 1991 | 0.060 |
Why?
|
Pyrroles | 1 | 2011 | 1130 | 0.060 |
Why?
|
Genomic Instability | 1 | 2009 | 704 | 0.060 |
Why?
|
Spectrometry, Mass, Secondary Ion | 1 | 2024 | 15 | 0.060 |
Why?
|
Chromatin Immunoprecipitation | 3 | 2012 | 857 | 0.060 |
Why?
|
Indazoles | 2 | 2020 | 302 | 0.060 |
Why?
|
Genetics, Population | 1 | 2009 | 929 | 0.060 |
Why?
|
Immunoglobulin M | 3 | 2015 | 1529 | 0.060 |
Why?
|
Colonic Neoplasms | 1 | 2016 | 2523 | 0.060 |
Why?
|
Mycosis Fungoides | 2 | 2016 | 168 | 0.060 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2009 | 498 | 0.060 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2009 | 494 | 0.060 |
Why?
|
STAT Transcription Factors | 2 | 2014 | 188 | 0.060 |
Why?
|
Focal Adhesion Kinase 2 | 1 | 2023 | 87 | 0.060 |
Why?
|
Vacuum | 1 | 2023 | 65 | 0.060 |
Why?
|
Drug Approval | 1 | 2010 | 808 | 0.060 |
Why?
|
Embryonic Stem Cells | 1 | 2011 | 1262 | 0.060 |
Why?
|
Central Nervous System | 1 | 2011 | 1333 | 0.060 |
Why?
|
Point Mutation | 1 | 2009 | 1593 | 0.050 |
Why?
|
Interleukin Receptor Common gamma Subunit | 2 | 2014 | 85 | 0.050 |
Why?
|
Graft Survival | 2 | 2011 | 3794 | 0.050 |
Why?
|
Mitochondria | 1 | 2016 | 3584 | 0.050 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2012 | 1373 | 0.050 |
Why?
|
Macrophage Inflammatory Proteins | 1 | 2002 | 121 | 0.050 |
Why?
|
Massachusetts | 1 | 2016 | 8823 | 0.050 |
Why?
|
Chemokine CCL20 | 1 | 2002 | 63 | 0.050 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2006 | 586 | 0.050 |
Why?
|
Receptors, CCR6 | 1 | 2002 | 73 | 0.050 |
Why?
|
Prediabetic State | 1 | 2008 | 547 | 0.050 |
Why?
|
DNA Viruses | 1 | 2022 | 34 | 0.050 |
Why?
|
Interleukin-4 | 3 | 2015 | 1130 | 0.050 |
Why?
|
Adipocytes | 1 | 2009 | 1177 | 0.050 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 3020 | 0.050 |
Why?
|
Nocardia | 1 | 2001 | 9 | 0.050 |
Why?
|
Lymphocyte Count | 2 | 2016 | 778 | 0.050 |
Why?
|
Antigens, Viral, Tumor | 1 | 2022 | 153 | 0.050 |
Why?
|
Exons | 1 | 2008 | 2387 | 0.050 |
Why?
|
Chemokines, CC | 1 | 2002 | 283 | 0.050 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2022 | 169 | 0.050 |
Why?
|
Histone Demethylases | 2 | 2016 | 319 | 0.050 |
Why?
|
Gene Deletion | 3 | 2014 | 2666 | 0.050 |
Why?
|
Methylation | 2 | 2016 | 1080 | 0.050 |
Why?
|
Child, Preschool | 4 | 2024 | 42062 | 0.050 |
Why?
|
Azacitidine | 1 | 2023 | 334 | 0.050 |
Why?
|
Janus Kinase 1 | 2 | 1998 | 107 | 0.050 |
Why?
|
Piperazines | 1 | 2012 | 2511 | 0.050 |
Why?
|
Leukoplakia, Oral | 1 | 2021 | 77 | 0.050 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2002 | 178 | 0.050 |
Why?
|
Antibodies, Viral | 1 | 2012 | 3142 | 0.050 |
Why?
|
Monitoring, Immunologic | 1 | 2021 | 98 | 0.050 |
Why?
|
Amygdala | 1 | 2009 | 1350 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2016 | 691 | 0.050 |
Why?
|
Germ-Line Mutation | 1 | 2009 | 1840 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3586 | 0.050 |
Why?
|
In Situ Hybridization | 2 | 2015 | 1900 | 0.050 |
Why?
|
Risk Factors | 7 | 2019 | 73809 | 0.050 |
Why?
|
Sucrose | 1 | 2021 | 156 | 0.050 |
Why?
|
STAT3 Transcription Factor | 2 | 2011 | 868 | 0.050 |
Why?
|
DNA Methylation | 3 | 2019 | 4373 | 0.050 |
Why?
|
RNA Interference | 3 | 2016 | 2836 | 0.040 |
Why?
|
Graft Rejection | 2 | 2010 | 4426 | 0.040 |
Why?
|
Administration, Oral | 3 | 2013 | 3991 | 0.040 |
Why?
|
Loss of Heterozygosity | 1 | 2022 | 659 | 0.040 |
Why?
|
Fear | 1 | 2009 | 1462 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 4 | 2016 | 17768 | 0.040 |
Why?
|
Heart Transplantation | 2 | 2011 | 3220 | 0.040 |
Why?
|
Chromosomes | 1 | 2023 | 575 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2015 | 555 | 0.040 |
Why?
|
Infusions, Intravenous | 2 | 2017 | 2210 | 0.040 |
Why?
|
Toll-Like Receptors | 1 | 2023 | 590 | 0.040 |
Why?
|
Child | 7 | 2024 | 79818 | 0.040 |
Why?
|
Splenectomy | 1 | 2001 | 391 | 0.040 |
Why?
|
HeLa Cells | 2 | 2020 | 3096 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2016 | 1125 | 0.040 |
Why?
|
Sequence Analysis, DNA | 3 | 2016 | 4711 | 0.040 |
Why?
|
Follow-Up Studies | 6 | 2021 | 39059 | 0.040 |
Why?
|
Promoter Regions, Genetic | 3 | 2018 | 5779 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2023 | 568 | 0.040 |
Why?
|
Aneuploidy | 1 | 2023 | 551 | 0.040 |
Why?
|
Immunity, Humoral | 2 | 2017 | 604 | 0.040 |
Why?
|
Leishmania donovani | 1 | 2000 | 68 | 0.040 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2019 | 40 | 0.040 |
Why?
|
South America | 1 | 2019 | 180 | 0.040 |
Why?
|
Genetic Testing | 1 | 2012 | 3530 | 0.040 |
Why?
|
Membrane Proteins | 2 | 2013 | 7843 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 3801 | 0.040 |
Why?
|
Mice, Congenic | 1 | 2019 | 97 | 0.040 |
Why?
|
Chemokine CXCL9 | 1 | 2019 | 135 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2017 | 13447 | 0.040 |
Why?
|
Dendritic Spines | 1 | 2021 | 243 | 0.040 |
Why?
|
Leishmaniasis, Visceral | 1 | 2000 | 99 | 0.040 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2013 | 714 | 0.040 |
Why?
|
Hematopoietic Stem Cells | 3 | 2019 | 3384 | 0.040 |
Why?
|
Immunoglobulin Variable Region | 2 | 2011 | 419 | 0.040 |
Why?
|
Opportunistic Infections | 1 | 2001 | 375 | 0.040 |
Why?
|
Viral Load | 2 | 2022 | 3321 | 0.040 |
Why?
|
RNA, Double-Stranded | 1 | 2020 | 295 | 0.040 |
Why?
|
Chemokine CCL5 | 1 | 2019 | 215 | 0.040 |
Why?
|
Peptides | 1 | 2010 | 4341 | 0.040 |
Why?
|
Mesenchymal Stem Cells | 1 | 2009 | 1634 | 0.040 |
Why?
|
Leukopoiesis | 1 | 1998 | 55 | 0.040 |
Why?
|
Cytokine Receptor gp130 | 1 | 1998 | 66 | 0.040 |
Why?
|
Lymphocytic Choriomeningitis | 1 | 2019 | 139 | 0.040 |
Why?
|
Receptors, CXCR3 | 1 | 2019 | 238 | 0.040 |
Why?
|
RNA, Antisense | 1 | 2018 | 136 | 0.040 |
Why?
|
Lymphocytic choriomeningitis virus | 1 | 2019 | 177 | 0.040 |
Why?
|
DNA Modification Methylases | 1 | 2018 | 209 | 0.040 |
Why?
|
RNA, Messenger | 4 | 2015 | 12759 | 0.040 |
Why?
|
Organogenesis | 1 | 2019 | 215 | 0.040 |
Why?
|
Case-Control Studies | 4 | 2024 | 22029 | 0.040 |
Why?
|
Paracrine Communication | 1 | 2019 | 276 | 0.040 |
Why?
|
Hydrogels | 1 | 2023 | 723 | 0.040 |
Why?
|
HIV-1 | 2 | 2012 | 6850 | 0.040 |
Why?
|
Ferritins | 1 | 2020 | 597 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3754 | 0.040 |
Why?
|
RNA, Small Interfering | 2 | 2016 | 3432 | 0.040 |
Why?
|
Interleukin-12 | 1 | 2000 | 583 | 0.040 |
Why?
|
Plasma Cells | 2 | 2011 | 591 | 0.040 |
Why?
|
Necrosis | 1 | 2001 | 1604 | 0.040 |
Why?
|
Peptide Elongation Factor G | 1 | 2016 | 12 | 0.040 |
Why?
|
Peptide Elongation Factor Tu | 1 | 2016 | 18 | 0.040 |
Why?
|
Receptors, Interleukin-2 | 1 | 1998 | 562 | 0.040 |
Why?
|
Adrenalectomy | 1 | 2019 | 348 | 0.040 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2021 | 617 | 0.030 |
Why?
|
Positron-Emission Tomography | 3 | 2022 | 6457 | 0.030 |
Why?
|
Cluster Analysis | 2 | 2016 | 2697 | 0.030 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2016 | 37 | 0.030 |
Why?
|
DNA Repair Enzymes | 1 | 2018 | 344 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2020 | 1693 | 0.030 |
Why?
|
Prospective Studies | 5 | 2024 | 54137 | 0.030 |
Why?
|
Sarcoma | 1 | 2007 | 1785 | 0.030 |
Why?
|
Mechlorethamine | 1 | 2016 | 129 | 0.030 |
Why?
|
Subrenal Capsule Assay | 1 | 2016 | 27 | 0.030 |
Why?
|
Neurotoxicity Syndromes | 1 | 2020 | 300 | 0.030 |
Why?
|
Tissue Embedding | 1 | 2015 | 42 | 0.030 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2016 | 197 | 0.030 |
Why?
|
Acute Disease | 1 | 2006 | 7225 | 0.030 |
Why?
|
Data Mining | 1 | 2021 | 551 | 0.030 |
Why?
|
DNA Helicases | 1 | 2021 | 854 | 0.030 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2016 | 171 | 0.030 |
Why?
|
Interferon Regulatory Factor-1 | 1 | 2015 | 68 | 0.030 |
Why?
|
Down-Regulation | 2 | 2015 | 2904 | 0.030 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2024 | 8945 | 0.030 |
Why?
|
Neurons, Afferent | 1 | 1998 | 498 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2022 | 2316 | 0.030 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2015 | 39 | 0.030 |
Why?
|
Ovary | 1 | 2020 | 958 | 0.030 |
Why?
|
Skin Transplantation | 2 | 2011 | 1083 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2017 | 3617 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2019 | 1339 | 0.030 |
Why?
|
Chemokine CXCL10 | 1 | 2016 | 316 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2001 | 1063 | 0.030 |
Why?
|
Cell Separation | 2 | 2011 | 1720 | 0.030 |
Why?
|
Bleomycin | 1 | 2016 | 495 | 0.030 |
Why?
|
Fallopian Tubes | 1 | 2015 | 178 | 0.030 |
Why?
|
Radiotherapy Dosage | 1 | 2022 | 2896 | 0.030 |
Why?
|
Hematopoiesis | 2 | 2014 | 2047 | 0.030 |
Why?
|
Cytoprotection | 1 | 2015 | 199 | 0.030 |
Why?
|
Vinblastine | 1 | 2016 | 487 | 0.030 |
Why?
|
Etoposide | 1 | 2016 | 630 | 0.030 |
Why?
|
Oxidative Phosphorylation | 1 | 2016 | 495 | 0.030 |
Why?
|
DNA Damage | 2 | 2016 | 2439 | 0.030 |
Why?
|
Transplantation Immunology | 1 | 2016 | 532 | 0.030 |
Why?
|
Amino Acid Motifs | 1 | 2016 | 929 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1060 | 0.030 |
Why?
|
Cystectomy | 1 | 2019 | 697 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 960 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2010 | 1111 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2016 | 802 | 0.030 |
Why?
|
Janus Kinases | 1 | 2014 | 249 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8650 | 0.030 |
Why?
|
Syndecan-1 | 1 | 2014 | 163 | 0.030 |
Why?
|
Weaning | 1 | 2013 | 103 | 0.030 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 1 | 2013 | 112 | 0.030 |
Why?
|
Intermediate Filaments | 1 | 2014 | 172 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2022 | 2004 | 0.030 |
Why?
|
Visual Cortex | 1 | 2021 | 1089 | 0.030 |
Why?
|
Germ-Free Life | 1 | 2013 | 187 | 0.030 |
Why?
|
Thymus Gland | 1 | 1998 | 1244 | 0.030 |
Why?
|
Interleukin-13 | 1 | 2015 | 372 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 4 | 2019 | 20500 | 0.030 |
Why?
|
Litter Size | 1 | 2012 | 49 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2014 | 473 | 0.030 |
Why?
|
Breeding | 1 | 2012 | 51 | 0.030 |
Why?
|
Thrombocythemia, Essential | 1 | 2014 | 106 | 0.030 |
Why?
|
Binding Sites | 2 | 2012 | 6036 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2013 | 384 | 0.030 |
Why?
|
Organ Size | 1 | 1998 | 2252 | 0.030 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2013 | 99 | 0.030 |
Why?
|
Hyperoxia | 1 | 2015 | 250 | 0.030 |
Why?
|
Europe | 1 | 2019 | 3420 | 0.030 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2014 | 431 | 0.030 |
Why?
|
Rad51 Recombinase | 1 | 2013 | 188 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2640 | 0.030 |
Why?
|
Polycythemia Vera | 1 | 2014 | 160 | 0.030 |
Why?
|
HEK293 Cells | 2 | 2013 | 4257 | 0.030 |
Why?
|
RNA, Viral | 2 | 2012 | 2836 | 0.030 |
Why?
|
Salivary Gland Neoplasms | 1 | 2016 | 304 | 0.030 |
Why?
|
Blotting, Southern | 1 | 2013 | 777 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2014 | 705 | 0.030 |
Why?
|
Organisms, Genetically Modified | 1 | 2012 | 63 | 0.030 |
Why?
|
Intramolecular Oxidoreductases | 1 | 2012 | 105 | 0.030 |
Why?
|
Genes, erbB-2 | 1 | 2012 | 162 | 0.030 |
Why?
|
Dosage Compensation, Genetic | 1 | 2013 | 207 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2022 | 2634 | 0.030 |
Why?
|
Genes, p16 | 1 | 2012 | 159 | 0.030 |
Why?
|
Lysine | 1 | 2016 | 998 | 0.020 |
Why?
|
E2F Transcription Factors | 1 | 2012 | 269 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2014 | 655 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2016 | 743 | 0.020 |
Why?
|
Duffy Blood-Group System | 1 | 2012 | 60 | 0.020 |
Why?
|
Death | 1 | 2016 | 674 | 0.020 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily K | 1 | 2012 | 95 | 0.020 |
Why?
|
Benzoquinones | 1 | 2012 | 198 | 0.020 |
Why?
|
Time Factors | 3 | 2019 | 39872 | 0.020 |
Why?
|
Soybean Oil | 1 | 2012 | 139 | 0.020 |
Why?
|
Plant Oils | 1 | 2012 | 197 | 0.020 |
Why?
|
STAT5 Transcription Factor | 1 | 2012 | 263 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2011 | 2057 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3527 | 0.020 |
Why?
|
Receptors, Cell Surface | 2 | 2012 | 2825 | 0.020 |
Why?
|
Lung | 1 | 2010 | 9985 | 0.020 |
Why?
|
Age Factors | 3 | 2017 | 18358 | 0.020 |
Why?
|
Animals, Genetically Modified | 1 | 2016 | 1553 | 0.020 |
Why?
|
Receptors, Calcitriol | 1 | 2014 | 359 | 0.020 |
Why?
|
Karyotyping | 1 | 2013 | 1171 | 0.020 |
Why?
|
Crystallization | 1 | 2012 | 533 | 0.020 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2012 | 226 | 0.020 |
Why?
|
Foreskin | 1 | 2011 | 31 | 0.020 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2012 | 256 | 0.020 |
Why?
|
Leupeptins | 1 | 2011 | 113 | 0.020 |
Why?
|
Immune System | 1 | 2016 | 796 | 0.020 |
Why?
|
Symbiosis | 1 | 2013 | 291 | 0.020 |
Why?
|
Genes, Immunoglobulin | 1 | 2011 | 285 | 0.020 |
Why?
|
Blood Cells | 1 | 2013 | 305 | 0.020 |
Why?
|
Hepatocyte Growth Factor | 1 | 2012 | 267 | 0.020 |
Why?
|
Connective Tissue Growth Factor | 1 | 2011 | 91 | 0.020 |
Why?
|
Luminescent Measurements | 1 | 2012 | 341 | 0.020 |
Why?
|
Lactams, Macrocyclic | 1 | 2012 | 315 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2016 | 977 | 0.020 |
Why?
|
North America | 1 | 2014 | 1276 | 0.020 |
Why?
|
Protein Stability | 1 | 2012 | 566 | 0.020 |
Why?
|
5-Methylcytosine | 1 | 2011 | 146 | 0.020 |
Why?
|
United States | 5 | 2019 | 72136 | 0.020 |
Why?
|
Immunologic Factors | 2 | 2010 | 1585 | 0.020 |
Why?
|
Ki-67 Antigen | 1 | 2012 | 631 | 0.020 |
Why?
|
Interleukin-6 | 2 | 2010 | 3208 | 0.020 |
Why?
|
Prostatectomy | 1 | 2019 | 1956 | 0.020 |
Why?
|
Tensile Strength | 1 | 2011 | 330 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2016 | 2569 | 0.020 |
Why?
|
CpG Islands | 1 | 2014 | 1221 | 0.020 |
Why?
|
Enzyme Inhibitors | 2 | 2011 | 3709 | 0.020 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2011 | 223 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4336 | 0.020 |
Why?
|
Brain | 3 | 2016 | 26947 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2013 | 1751 | 0.020 |
Why?
|
Cullin Proteins | 1 | 2011 | 178 | 0.020 |
Why?
|
Paraproteinemias | 1 | 2012 | 246 | 0.020 |
Why?
|
Birth Weight | 1 | 1998 | 2097 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2010 | 622 | 0.020 |
Why?
|
Genes, jun | 1 | 2009 | 68 | 0.020 |
Why?
|
Benzylamines | 1 | 2010 | 247 | 0.020 |
Why?
|
MAP Kinase Kinase Kinase 5 | 1 | 2009 | 20 | 0.020 |
Why?
|
Maximum Tolerated Dose | 1 | 2012 | 876 | 0.020 |
Why?
|
Receptors, Growth Factor | 1 | 2010 | 326 | 0.020 |
Why?
|
Kinetics | 2 | 2012 | 6371 | 0.020 |
Why?
|
Protein Kinases | 1 | 2016 | 1610 | 0.020 |
Why?
|
Heterocyclic Compounds | 1 | 2010 | 246 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2012 | 11336 | 0.020 |
Why?
|
ADAM Proteins | 1 | 2011 | 238 | 0.020 |
Why?
|
Serum | 1 | 2011 | 210 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2011 | 869 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2016 | 1788 | 0.020 |
Why?
|
I-kappa B Kinase | 1 | 2010 | 250 | 0.020 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2010 | 293 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2016 | 1737 | 0.020 |
Why?
|
Bloom Syndrome | 1 | 2009 | 10 | 0.020 |
Why?
|
Dysgerminoma | 1 | 2009 | 66 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2010 | 276 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 1647 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 698 | 0.020 |
Why?
|
Interleukin-2 Receptor beta Subunit | 1 | 2009 | 25 | 0.020 |
Why?
|
Immunoglobulin Switch Region | 1 | 2009 | 45 | 0.020 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2010 | 377 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2012 | 345 | 0.020 |
Why?
|
Hemoglobins | 1 | 2015 | 1519 | 0.020 |
Why?
|
Radiation Chimera | 1 | 2009 | 216 | 0.020 |
Why?
|
Dermatitis, Allergic Contact | 1 | 2010 | 111 | 0.020 |
Why?
|
Internationality | 1 | 2014 | 1000 | 0.020 |
Why?
|
Antilymphocyte Serum | 1 | 2010 | 482 | 0.020 |
Why?
|
Inflammation | 2 | 2023 | 10718 | 0.020 |
Why?
|
Ovalbumin | 1 | 2010 | 673 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2129 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3796 | 0.020 |
Why?
|
Immunoglobulin Isotypes | 1 | 2009 | 158 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2012 | 1527 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3812 | 0.020 |
Why?
|
DNA Primers | 1 | 2013 | 2816 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2009 | 451 | 0.020 |
Why?
|
Germinoma | 1 | 2009 | 132 | 0.020 |
Why?
|
Respiration | 1 | 2015 | 1654 | 0.020 |
Why?
|
Methylcholanthrene | 1 | 2007 | 31 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2013 | 1110 | 0.020 |
Why?
|
Carrier Proteins | 2 | 2011 | 4938 | 0.020 |
Why?
|
Jurkat Cells | 1 | 2009 | 735 | 0.020 |
Why?
|
Patient Selection | 1 | 2020 | 4244 | 0.020 |
Why?
|
Genes, RAG-1 | 1 | 2007 | 67 | 0.020 |
Why?
|
Leukemia | 1 | 2016 | 1519 | 0.020 |
Why?
|
Immunity, Active | 1 | 2007 | 58 | 0.020 |
Why?
|
Seminoma | 1 | 2009 | 134 | 0.020 |
Why?
|
Teratoma | 1 | 2011 | 403 | 0.020 |
Why?
|
Antigens, Ly | 1 | 2009 | 292 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2011 | 675 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 640 | 0.020 |
Why?
|
Fibroblasts | 1 | 1998 | 4087 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2012 | 1974 | 0.020 |
Why?
|
Models, Biological | 2 | 2016 | 9460 | 0.020 |
Why?
|
Receptors, Metabotropic Glutamate | 1 | 2009 | 195 | 0.020 |
Why?
|
Receptors, Androgen | 1 | 2014 | 1077 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2010 | 651 | 0.020 |
Why?
|
Immunocompetence | 1 | 2007 | 138 | 0.020 |
Why?
|
Long-Term Potentiation | 1 | 2009 | 293 | 0.020 |
Why?
|
Carboplatin | 1 | 2010 | 788 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2011 | 2013 | 0.020 |
Why?
|
Neutropenia | 1 | 2012 | 884 | 0.020 |
Why?
|
DNA Repair | 1 | 2016 | 2038 | 0.020 |
Why?
|
Albumins | 1 | 2010 | 575 | 0.020 |
Why?
|
Uterus | 1 | 2011 | 651 | 0.020 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2008 | 305 | 0.020 |
Why?
|
Cell Polarity | 1 | 2010 | 638 | 0.020 |
Why?
|
Living Donors | 1 | 2011 | 638 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 2269 | 0.020 |
Why?
|
Caspases | 1 | 2010 | 876 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2012 | 2057 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2012 | 724 | 0.020 |
Why?
|
Infant | 2 | 2024 | 36055 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1610 | 0.020 |
Why?
|
Microvessels | 1 | 2011 | 572 | 0.020 |
Why?
|
Gene Frequency | 1 | 2013 | 3612 | 0.020 |
Why?
|
Genes, ras | 1 | 2009 | 654 | 0.020 |
Why?
|
Isoenzymes | 1 | 2011 | 1686 | 0.020 |
Why?
|
Endothelium | 1 | 2009 | 764 | 0.020 |
Why?
|
Smoking | 2 | 2015 | 9051 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2011 | 4169 | 0.020 |
Why?
|
Ubiquitination | 1 | 2011 | 1006 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2011 | 1228 | 0.020 |
Why?
|
Cell Death | 1 | 2011 | 1668 | 0.020 |
Why?
|
Mesoderm | 1 | 2009 | 672 | 0.020 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2010 | 677 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2014 | 2210 | 0.020 |
Why?
|
Epigenomics | 1 | 2011 | 936 | 0.020 |
Why?
|
Fatigue | 1 | 2012 | 1542 | 0.020 |
Why?
|
Models, Immunological | 1 | 2007 | 513 | 0.020 |
Why?
|
Myocardium | 1 | 1998 | 4690 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2011 | 1120 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2009 | 800 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2016 | 4342 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1600 | 0.020 |
Why?
|
Rabbits | 1 | 2011 | 4772 | 0.010 |
Why?
|
Oligopeptides | 1 | 2010 | 1185 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2010 | 2925 | 0.010 |
Why?
|
Liver | 1 | 2000 | 7502 | 0.010 |
Why?
|
Chromatin | 1 | 2016 | 2938 | 0.010 |
Why?
|
Cholesterol | 1 | 2013 | 2902 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2009 | 1526 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2012 | 3774 | 0.010 |
Why?
|
Medulloblastoma | 1 | 2009 | 679 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2021 | 4761 | 0.010 |
Why?
|
Causality | 1 | 2009 | 1241 | 0.010 |
Why?
|
Virus Replication | 1 | 2011 | 2430 | 0.010 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 1651 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2011 | 1958 | 0.010 |
Why?
|
Paclitaxel | 1 | 2010 | 1728 | 0.010 |
Why?
|
Cell Division | 1 | 2010 | 4458 | 0.010 |
Why?
|
Colon | 1 | 2011 | 1787 | 0.010 |
Why?
|
Synaptic Transmission | 1 | 2009 | 1169 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2010 | 1927 | 0.010 |
Why?
|
Th2 Cells | 1 | 2007 | 1047 | 0.010 |
Why?
|
Autophagy | 1 | 2010 | 1322 | 0.010 |
Why?
|
DNA Replication | 1 | 2009 | 1410 | 0.010 |
Why?
|
Stem Cells | 1 | 2014 | 3521 | 0.010 |
Why?
|
Pancreas | 1 | 2008 | 1676 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2011 | 1887 | 0.010 |
Why?
|
Models, Molecular | 1 | 2011 | 5410 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2895 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2011 | 2047 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2009 | 2943 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2009 | 2693 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2011 | 6293 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2010 | 2144 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25956 | 0.010 |
Why?
|
Hyperglycemia | 1 | 2009 | 1368 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12096 | 0.010 |
Why?
|
MicroRNAs | 1 | 2015 | 3783 | 0.010 |
Why?
|
Genome, Human | 1 | 2012 | 4416 | 0.010 |
Why?
|
Kidney | 1 | 2014 | 7016 | 0.010 |
Why?
|
Computational Biology | 1 | 2011 | 3502 | 0.010 |
Why?
|
Nanoparticles | 1 | 2010 | 1940 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 2011 | 2476 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2007 | 2297 | 0.010 |
Why?
|
Risk Assessment | 1 | 2019 | 23884 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7403 | 0.010 |
Why?
|
Phosphotyrosine | 1 | 1998 | 455 | 0.010 |
Why?
|
src Homology Domains | 1 | 1998 | 361 | 0.010 |
Why?
|
Odds Ratio | 1 | 2010 | 9650 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2010 | 4158 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2010 | 3533 | 0.010 |
Why?
|
Chronic Disease | 1 | 2012 | 9267 | 0.010 |
Why?
|
Cytopathogenic Effect, Viral | 1 | 1996 | 151 | 0.010 |
Why?
|
Vesicular stomatitis Indiana virus | 1 | 1996 | 92 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10504 | 0.010 |
Why?
|
Logistic Models | 1 | 2010 | 13276 | 0.010 |
Why?
|
Skin | 1 | 2009 | 4464 | 0.010 |
Why?
|
DNA Probes | 1 | 1996 | 543 | 0.010 |
Why?
|
STAT1 Transcription Factor | 1 | 1996 | 333 | 0.010 |
Why?
|
Algorithms | 1 | 2014 | 13961 | 0.010 |
Why?
|
Interferon-alpha | 1 | 1996 | 918 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 1996 | 2204 | 0.000 |
Why?
|
Rats | 1 | 1996 | 23679 | 0.000 |
Why?
|